论文部分内容阅读
目的 :探讨48例小儿哮喘患者应用特布他林联合布地奈德雾化吸入的疗效。方法 :选取2014年5月至2015年5月我院儿科收治的小儿哮喘患儿共96例,按照随机数表法将其分为两组,观察组与对照组各48例,对照组患者采取常规治疗,观察组患者应用特布他林联合布地奈德雾化吸入治疗,对比两组患者的治疗效果。结果 :两组患儿的治疗总有效率分别为97.92%、83.33%,观察组患儿治疗效果明显优于对照组患儿,两组疗效对比差异有统计学意义,P<0.05。结论 :应用特布他林联合布地奈德雾化吸入治疗小儿哮喘疗效显著,具有较高的安全性和可行性,值得临床推广应用。
Objective: To investigate the efficacy of inhalation of terbutaline combined with budesonide in 48 pediatric patients with asthma. Methods: A total of 96 children with pediatric asthma admitted to our hospital from May 2014 to May 2015 were selected and divided into two groups according to the random number table method. The observation group and the control group were treated with 48 cases each. The control group The patients in the observation group were treated with inhalation of terbutaline combined with budesonide, and the treatment effect was compared between the two groups. Results: The total effective rates of two groups of children were 97.92% and 83.33%, respectively. The treatment effect in the observation group was significantly better than that in the control group. There was significant difference in curative effect between the two groups (P <0.05). Conclusion: The therapeutic effect of terbutaline combined with budesonide inhalation on pediatric asthma is significant, which has high safety and feasibility and is worthy of clinical application.